Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives

Nineteen erlotinib derivatives bearing different 1,2,3-triazole moieties were designed, synthesized, and evaluated for their potential against different cancer cell lines. The structures of the synthesized compounds were confirmed via1H NMR, 13C NMR, and HR MS. Preliminary antitumor activity assay r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Long-fei Mao, Zhen-Zhen Wang, Qiong Wu, Xiaojie Chen, Jian-Xue Yang, Xin Wang, Yue-Ming Li
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2022-04-01
Colección:Frontiers in Pharmacology
Materias:
erlotinib
EGFR
anticancer
drug-resistant cancer cell lines
1,2,3-triazole
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fphar.2022.849364/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares